Pharmaceutical Technology ePT Weekly
Having trouble viewing this e-mail? CLICK HERE
advertisement
PharmTech
May 7, 2020
PHARMTECH.COM CURRENT ISSUE SUBSCRIBE FORWARD
advertisement

In this issue:

Second “Cures” Bill Promotes Pandemic Preparedness

Former 3M Drug Delivery Systems Launches as Kindeva Drug Delivery

Lonza, Moderna Form Global Collaboration to Manufacture Moderna’s COVID-19 Vaccine


Top Stories

COVID-19 Update

Updates on COVID-19 vaccine candidates, FDA policies, company partnerships, and more.
/ read more /


Remdesivir Approved for Emergency Use

FDA’s EUA provides the first new treatment for COVID-19 patients with severe symptoms.
/ read more /

 

Industry News

Second “Cures” Bill Promotes Pandemic Preparedness

Congressional leaders are developing the next version of the 21st Century Cures Act, including provisions to advance research related to the COVID-19 crisis as part of initiatives for bringing innovative therapies to market faster.
/ read more /


New ASTM Standard Addresses Foreign Particles in Biomanufacturing Processes

The ASTM standard describes how to evaluate single-use systems for foreign particle analysis.
/ read more /


More Industry News
advertisement

Subscribe

Subscribers can enjoy each full issue of Pharm Tech in print, or via Pharm Tech apps.

subscription offers
subscribe
 
 

advertisement
 
advertisement

The Leader in Spray Drying
With the largest capacity, the best scale-up science and the most experienced team, Hovione secures your project from early-phase development to commercial and accelerates your time to market.

Spray drying offers a number of advantages, including: Enhanced bioavailability of poorly soluble compounds, amorphous solid dispersions, inhalation formulations and enables taste-masking or controlled release dosage forms.


/ Talk to the leader. /


Supplier News

Fujifilm Diosynth Biotechnologies Reserves Capacity for COVID-19 Therapeutics Accelerator

Fujifilm allocates production volumes for COVID-19 treatments in 2021 at its Denmark facility.
/ read more /


Former 3M Drug Delivery Systems Launches as Kindeva Drug Delivery

Kindeva Drug Delivery plans capital investment and jobs growth.
/ read more /


More Supplier News


 

Bio/Pharma News

AMRI Announces Increased Production of Hydroxychloroquine Sulfate for COVID-19 Treatment

FDA approved hydroxychloroquine sulfate for emergency use as a treatment for some hospitalized patients with COVID-19.
/ read more /


Lonza, Moderna Form Global Collaboration to Manufacture Moderna’s COVID-19 Vaccine

The goal of the collaboration is to manufacture up to one billion does per year of mRNA-1273, Moderna’s vaccine against the novel coronavirus.
/ read more /


More Bio/Pharma News

 
 

Regulatory News

EMA Endorses Statement Pledging to Fight COVID-19

The statement, published by the International Coalition of Medicines Regulatory Authorities, outlined its commitment to a strengthening of global collaboration in the fight against COVID-19.
/ read more /


Merck & Co.’s Keytruda Approved by FDA for Additional Recommended Dose

The approval was based on pharmacokinetic data, the relationship of exposure to efficacy, and the relationship of exposure to safety.
/ read more /


More Regulatory News

 
 
 
 
 

Featured Topics

FORMULATION

Delivering the Goods

The new molecules entering the development pipeline are bringing forth exciting challenges in drug delivery.
/ read more /


FILL-FINISH

Considerations for Sterile Filtration of Biologic Drugs

Sterile filtration is often required for biologics but presents degradation and compatibility challenges.
/ read more /

 
DRUG DEVELOPMENT

Choices for Climbing the Career Ladder

With a positive employment market, some bio/pharma professionals explore options for career advancement.
/ read more /


QUALITY/REGULATIONS

Navigating GMPs for Gene Therapies

While new industry guidance documents issued by FDA speak to the agency’s efforts to promote the development of new gene therapies, certain hurdles remain to challenge stakeholders.
/ read more /

 
 
 

WEBCASTS

Ensuring Integrity of Drug Formulation from Development to QC
Thursday, May 21, 2020 at 10am EDT | 9am CDT | 3pm BST | 4pm CEST
Learn More


Bulletproof your Supply Chain: Hope for the Best, Prepare for the Worst
Monday, May 18, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Learn More


Through Container Verification of Pharmaceutical Raw Materials with the New Agilent Vaya Handheld Raman System
Europe Broadcast: Thursday, May 14, 2020 at 9am EDT | 2pm BST | 3pm CEST
US Broadcast: Thursday, May 14, 2020 at 2pm EDT | 1pm CDT | 11am PDT
Asia Pacific Broadcast: Friday, May 15, 2020 at 8:30am IST | 11am CST | 12pm JST | 1pm AEST
Learn More


Practical Considerations for Bringing Drug Candidates to Phase I Clinical Trial
Wednesday, May 27, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Learn More


When Drug Meets Device: How to Assess Compatibility
Tuesday, May 19, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Learn More

 

Rescheduled Events

CPhI South East Asia

CPhI South East Asia has been rescheduled for July 2020.

Interphex 2020

Interphex 2020 has been rescheduled for July 2020.

69th PDA Annual Meeting

PDA’s Annual Meeting has been rescheduled for July 2020.

Bioprocessing Summit Europe

Bioprocessing Summit Europe has been rescheduled for July 2020.

PDA Pharmaceutical Manufacturing Data Science Workshop

PDA’s Pharmaceutical Manufacturing Data Science Workshop has been rescheduled for July 2020.

Validation University

Validation University has been rescheduled for August 2020.

CPhI North America

CPhI North America has been rescheduled for September 2020.

CPhI Japan

CPhI Japan has been rescheduled for September 2020

Analytica 2020

Analytica 2020 has been rescheduled for October 2020.

Interpack 2020

Interpack 2020 has been rescheduled for February 2021.

more events

eBOOKS

Regulatory Sourcebook and Reference, March 2020

The Pharmacopoeia Compliance Series features a description of ways bio/pharma companies can participate in monograph development, a practical approach to pharmacopoeial compliance, and a summary of this 12-part series.


contribute | contact editors | CONTACT SALES | subscribe | advertise